RB1 and neoplasm: Pharmacokinetic–pharmacodynamic relationships were established in the HCT116 human colon cancer xenograft model and showed reduced phosphorylation of RB and decreased expression of cyclin D1 in tumour tissue (Raynaud et al, 2005).